Skip to main content
Atrás
Watch Compare

Q32 Bio Inc.

Calidad de datos: 100%
QTTB
Nasdaq Manufacturing Chemicals
$5.05
▲ $0.13 (2.64%)
Cap. Mercado: 72.42 M
Precio
$4.95
Cap. Mercado
72.42 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Revenue grew 12.15% annually over 5 years — strong growth
Net margin of 55.49% shows strong profitability
Negative free cash flow of -33.54 M
P/E of 2.43 — trading at a low valuation
Capital efficient — spends only 0.00% of revenue on capex
ROIC of 33.38% — excellent capital efficiency

Crecimiento

Revenue Growth (5Y)
12.15%
Above sector avg (1.82%)
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROIC33.38%
Net Margin55.49%
Op. Margin31.45%

Seguridad

Debt / Equity
N/A
Current Ratio4.57
Interest Coverage16.02

Valoración

PE (TTM)
2.43
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDA1.38
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1366 pares)
Métrica Acción Mediana del Sector
P/E 2.4 -1.5
P/B — 1.6
ROE % — -53.5
Net Margin % 55.5 -41.5
Rev Growth 5Y % 12.2 1.8
D/E — 0.3

Precio Objetivo de Analistas

3 analistas
Buy
Actual
$5.05
+183.8%
Objetivo
$14.33
$10.00
$13.00
$20.00
Pronóstico
EPS Futuro -$3.39
Ingresos Est. 0.0

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2027 -$3.39
-$5.05 – -$2.06
 0.0 3
FY2026 -$2.09
-$2.93 – -$1.13
 0.0 3

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q42025 -$0.86 $4.58 +632.6%
Q32025 -$1.19 -$0.60 +49.6%
Q22025 -$0.98 -$0.78 +20.4%
Q12025 -$1.23 -$0.90 +26.8%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) 581.80%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 12.15% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 53.74 M Net Income (TTM) 29.82 M
ROE N/A ROA 48.14%
Gross Margin N/A Operating Margin 31.45%
Net Margin 55.49% Free Cash Flow (TTM) -33.54 M
ROIC 33.38% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4.57
Interest Coverage 16.02 Asset Turnover 0.87
Working Capital 39.70 M Tangible Book Value -18.45 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 2.43 Forward P/E N/A
P/B Ratio N/A P/S Ratio 1.35
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 1.38 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -46.32%
Market Cap 72.42 M Enterprise Value 23.38 M
Per Share
EPS (Diluted TTM) 2.42 Revenue / Share 3.67
FCF / Share -2.29 OCF / Share -2.29
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.00% FCF Conversion -112.48%
SBC-Adj. FCF -38.71 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 53.74 M 0.0 1.16 M 3.21 M 33.97 M
Net Income 29.82 M -47.73 M -112.96 M -5.01 M -95.76 M
EPS (Diluted) 2.42 -6.58 -1.95 -0.09 —
Gross Profit — — — — —
Operating Income 16.90 M -66.10 M -101.43 M -133.28 M -95.95 M
EBITDA — — — — —
R&D Expenses 19.16 M 48.14 M 62.00 M 98.35 M 93.09 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 1.06 M 1.50 M — — —
Income Tax 0.0 21,000.0 0.0 715,000.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 61.78 M 92.33 M 84.56 M 228.47 M 211.72 M
Total Liabilities 19.76 M 86.66 M 11.57 M 50.49 M 42.07 M
Shareholders' Equity 42.01 M 5.68 M 72.99 M 177.98 M 169.65 M
Total Debt — — — — —
Cash & Equivalents 48.30 M 77.97 M 39.27 M 33.99 M 108.38 M
Current Assets 55.05 M 81.88 M 83.91 M 181.02 M 191.91 M
Current Liabilities 11.35 M 16.47 M 11.57 M 22.58 M 17.23 M